Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Fate Therapeutics Inc. (FATE)

15.95   -0.19 (-1.18%) 03-25 13:57
Open: 16.09 Pre. Close: 16.14
High: 16.51 Low: 15.604
Volume: 297,483 Market Cap: 1037M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 17.79 - 17.889 17.889 - 17.969
Low: 15.846 - 15.976 15.976 - 16.082
Close: 15.95 - 16.142 16.142 - 16.298

Technical analysis

as of: 2019-03-25 1:29:47 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 19.97     One year: 22.32
Support: Support1: 13.85    Support2: 11.52
Resistance: Resistance1: 17.10    Resistance2: 19.11
Pivot: 17.08
Moving Average: MA(5): 17.10     MA(20): 16.84
MA(100): 14.89     MA(250): 13.01
MACD: MACD(12,26): 0.48     Signal(9): 0.65
Stochastic oscillator: %K(14,3): 28.50     %D(3): 45.51
RSI: RSI(14): 45.46
52-week: High: 19.11  Low: 8.35  Change(%): 37.7
Average Vol(K): 3-Month: 69757  10-Days: 74686

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
FATE has closed above bottom band by 21.4%. Bollinger Bands are 14.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 06 Mar 2019 08:06:28 Z
Fate Therapeutics Inc (FATE) Q4 2018 Earnings Conference Call Transcript

Tue, 05 Mar 2019 21:10:30 Z
After-Hours Earnings Report for March 5, 2019 : ROST, COO, URBN, AVAV, AMBA, SSW, FATE, REGI, AGS, UNFI, PARR, VSLR

Tue, 05 Mar 2019 20:26:33 Z
Earnings Reaction History: FATE THERAPEUTC, 60.0% Follow-Through Indicator, 6.0% Sensitive

Thu, 28 Feb 2019 18:15:25 Z
Cronos (CRON) to Report Q4 Earnings: What's in the Cards?

Mon, 25 Feb 2019 17:10:21 Z
Fate Therapeutics (FATE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 65.00
Shares Float (M) 64.00
% Held by Insiders 1.90
% Held by Institutions 135.70
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -1.200
EPS Est. Current Year -0.970
EPS Est. Next Year -0.940
EPS Est. Next Quarter -0.250
Forward EPS -1.060
Book Value (p.s.) 7.190
PEG Ratio
Profit Margin
Operating Margin -1415.44
Return on Assets (ttm) -41.8
Return on Equity (ttm) -56.0
Qtrly Rev. Growth 61.7
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -38.65
Levered Free Cash Flow (M) -26.45

Stock Valuations

P/E -13.27
P/E Growth Ratio -0.01
P/BV 2.22
P/S 12943124480.00
P/CF -26.79

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.